Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by Walleye101on Apr 04, 2007 8:19pm
77 Views
Post# 12551443

RE: late reportings and typos

RE: late reportings and typosI'm sure the news is coming, and it will, eventually. I began watching this when I heard the stroke benefits mentioned on Coast To Coast radio. It began to run a day prior to the airing. Frontloading??? maybe. Could have been a great pr set up. If the reporting delay continues, there's nothing wrong with taking profits. Thats what we are all here for. right? The above are my own insightful opinions.
Bullboard Posts